Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-06-26 @ 9:07 AM
Study NCT ID:
NCT05437120
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2022-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic Impairment
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cystic Fibrosis | View |
Keywords: